HEADER    ANTIBIOTIC                              05-JUN-97   1ALX              
TITLE     GRAMICIDIN D FROM BACILLUS BREVIS (METHANOL SOLVATE)                  
COMPND    MOL_ID: 1;                                                            
COMPND   2 MOLECULE: GRAMICIDIN A;                                              
COMPND   3 CHAIN: A;                                                            
COMPND   4 SYNONYM: VALYL GRAMICIDIN;                                           
COMPND   5 MOL_ID: 2;                                                           
COMPND   6 MOLECULE: GRAMICIDIN A;                                              
COMPND   7 CHAIN: B;                                                            
COMPND   8 SYNONYM: VALYL GRAMICIDIN                                            
SOURCE    MOL_ID: 1;                                                            
SOURCE   2 ORGANISM_SCIENTIFIC: BREVIBACILLUS BREVIS;                           
SOURCE   3 ORGANISM_TAXID: 1393;                                                
SOURCE   4 MOL_ID: 2;                                                           
SOURCE   5 ORGANISM_SCIENTIFIC: BREVIBACILLUS BREVIS;                           
SOURCE   6 ORGANISM_TAXID: 1393                                                 
KEYWDS    ANTIBIOTIC, GRAMICIDIN, ANTIFUNGAL, ANTIBACTERIAL, ABTIBIOTIC,        
KEYWDS   2 MEMBRANE ION CHANNEL, LINEAR GRAMICIDIN                              
EXPDTA    X-RAY DIFFRACTION                                                     
AUTHOR    B.M.BURKHART,D.A.LANGS,G.D.SMITH,C.COURSEILLE,G.PRECIGOUX,M.HOSPITAL, 
AUTHOR   2 W.A.PANGBORN,W.L.DUAX                                                
REVDAT   7   02-AUG-23 1ALX    1       SEQADV LINK                              
REVDAT   6   18-APR-18 1ALX    1       REMARK                                   
REVDAT   5   06-FEB-13 1ALX    1       REMARK                                   
REVDAT   4   27-JUL-11 1ALX    1       ATOM   DBREF  HETATM REMARK              
REVDAT   4 2                   1       SEQRES                                   
REVDAT   3   13-JUL-11 1ALX    1       VERSN                                    
REVDAT   2   24-FEB-09 1ALX    1       VERSN                                    
REVDAT   1   04-MAR-98 1ALX    0                                                
JRNL        AUTH   B.M.BURKHART,R.M.GASSMAN,D.A.LANGS,W.A.PANGBORN,W.L.DUAX     
JRNL        TITL   HETERODIMER FORMATION AND CRYSTAL NUCLEATION OF GRAMICIDIN D 
JRNL        REF    BIOPHYS.J.                    V.  75  2135 1998              
JRNL        REFN                   ISSN 0006-3495                               
JRNL        PMID   9788907                                                      
JRNL        DOI    10.1016/S0006-3495(98)77656-8                                
REMARK   1                                                                      
REMARK   1 REFERENCE 1                                                          
REMARK   1  AUTH   D.A.LANGS,G.D.SMITH,C.COURSEILLE,G.PRECIGOUX,M.HOSPITAL      
REMARK   1  TITL   MONOCLINIC UNCOMPLEXED DOUBLE-STRANDED, ANTIPARALLEL,        
REMARK   1  TITL 2 LEFT-HANDED BETA 5.6-HELIX (INCREASES DECREASES BETA 5.6)    
REMARK   1  TITL 3 STRUCTURE OF GRAMICIDIN A: ALTERNATE PATTERNS OF HELICAL     
REMARK   1  TITL 4 ASSOCIATION AND DEFORMATION                                  
REMARK   1  REF    PROC.NATL.ACAD.SCI.USA        V.  88  5345 1991              
REMARK   1  REFN                   ISSN 0027-8424                               
REMARK   1  PMID   1711230                                                      
REMARK   1  DOI    10.1073/PNAS.88.12.5345                                      
REMARK   2                                                                      
REMARK   2 RESOLUTION.    1.20 ANGSTROMS.                                       
REMARK   3                                                                      
REMARK   3 REFINEMENT.                                                          
REMARK   3   PROGRAM     : SHELXL-97                                            
REMARK   3   AUTHORS     : G.M.SHELDRICK                                        
REMARK   3                                                                      
REMARK   3  DATA USED IN REFINEMENT.                                            
REMARK   3   RESOLUTION RANGE HIGH (ANGSTROMS) : 1.20                           
REMARK   3   RESOLUTION RANGE LOW  (ANGSTROMS) : 100.00                         
REMARK   3   DATA CUTOFF            (SIGMA(F)) : 0.000                          
REMARK   3   COMPLETENESS FOR RANGE        (%) : 99.9                           
REMARK   3   CROSS-VALIDATION METHOD           : FREE R-VALUE                   
REMARK   3   FREE R VALUE TEST SET SELECTION   : 5% OF REFLECTIONS IN THIN      
REMARK   3                                       RESOLUTION SHELLS.             
REMARK   3                                                                      
REMARK   3  FIT TO DATA USED IN REFINEMENT (NO CUTOFF).                         
REMARK   3   R VALUE   (WORKING + TEST SET, NO CUTOFF) : 0.102                  
REMARK   3   R VALUE          (WORKING SET, NO CUTOFF) : 0.100                  
REMARK   3   FREE R VALUE                  (NO CUTOFF) : 0.168                  
REMARK   3   FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 5.000                  
REMARK   3   FREE R VALUE TEST SET COUNT   (NO CUTOFF) : 376                    
REMARK   3   TOTAL NUMBER OF REFLECTIONS   (NO CUTOFF) : 7726                   
REMARK   3                                                                      
REMARK   3  FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F).                     
REMARK   3   R VALUE   (WORKING + TEST SET, F>4SIG(F)) : 0.102                  
REMARK   3   R VALUE          (WORKING SET, F>4SIG(F)) : 0.100                  
REMARK   3   FREE R VALUE                  (F>4SIG(F)) : 0.168                  
REMARK   3   FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : 5.000                  
REMARK   3   FREE R VALUE TEST SET COUNT   (F>4SIG(F)) : 376                    
REMARK   3   TOTAL NUMBER OF REFLECTIONS   (F>4SIG(F)) : 7726                   
REMARK   3                                                                      
REMARK   3  NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.                    
REMARK   3   PROTEIN ATOMS      : 284                                           
REMARK   3   NUCLEIC ACID ATOMS : 0                                             
REMARK   3   HETEROGEN ATOMS    : 40                                            
REMARK   3   SOLVENT ATOMS      : 0                                             
REMARK   3                                                                      
REMARK   3  MODEL REFINEMENT.                                                   
REMARK   3   OCCUPANCY SUM OF NON-HYDROGEN ATOMS      : 315.41                  
REMARK   3   OCCUPANCY SUM OF HYDROGEN ATOMS          : 367.54                  
REMARK   3   NUMBER OF DISCRETELY DISORDERED RESIDUES : 5                       
REMARK   3   NUMBER OF LEAST-SQUARES PARAMETERS       : 3422                    
REMARK   3   NUMBER OF RESTRAINTS                     : 5704                    
REMARK   3                                                                      
REMARK   3  RMS DEVIATIONS FROM RESTRAINT TARGET VALUES.                        
REMARK   3   BOND LENGTHS                         (A) : 0.014                   
REMARK   3   ANGLE DISTANCES                      (A) : 0.031                   
REMARK   3   SIMILAR DISTANCES (NO TARGET VALUES) (A) : NULL                    
REMARK   3   DISTANCES FROM RESTRAINT PLANES      (A) : 0.326                   
REMARK   3   ZERO CHIRAL VOLUMES               (A**3) : 0.167                   
REMARK   3   NON-ZERO CHIRAL VOLUMES           (A**3) : 0.119                   
REMARK   3   ANTI-BUMPING DISTANCE RESTRAINTS     (A) : NULL                    
REMARK   3   RIGID-BOND ADP COMPONENTS         (A**2) : 0.006                   
REMARK   3   SIMILAR ADP COMPONENTS            (A**2) : 0.033                   
REMARK   3   APPROXIMATELY ISOTROPIC ADPS      (A**2) : 0.045                   
REMARK   3                                                                      
REMARK   3  BULK SOLVENT MODELING.                                              
REMARK   3   METHOD USED: MOEWS & KRETSINGER (G = 0.12792 U = 0.82322)          
REMARK   3                                                                      
REMARK   3  STEREOCHEMISTRY TARGET VALUES : ENGH AND HUBER                      
REMARK   3   SPECIAL CASE: MODIFIED ENGH AND HUBER FOR ETHANOLAMINE BASED ON    
REMARK   3                 SERINE                                               
REMARK   3                                                                      
REMARK   3  OTHER REFINEMENT REMARKS: NULL                                      
REMARK   4                                                                      
REMARK   4 1ALX COMPLIES WITH FORMAT V. 3.30, 13-JUL-11                         
REMARK 100                                                                      
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL.                                
REMARK 100 THE DEPOSITION ID IS D_1000170980.                                   
REMARK 200                                                                      
REMARK 200 EXPERIMENTAL DETAILS                                                 
REMARK 200  EXPERIMENT TYPE                : X-RAY DIFFRACTION                  
REMARK 200  DATE OF DATA COLLECTION        : JAN-90                             
REMARK 200  TEMPERATURE           (KELVIN) : 120                                
REMARK 200  PH                             : 7.0                                
REMARK 200  NUMBER OF CRYSTALS USED        : 1                                  
REMARK 200                                                                      
REMARK 200  SYNCHROTRON              (Y/N) : N                                  
REMARK 200  RADIATION SOURCE               : ROTATING ANODE                     
REMARK 200  BEAMLINE                       : NULL                               
REMARK 200  X-RAY GENERATOR MODEL          : RIGAKU RUH2R                       
REMARK 200  MONOCHROMATIC OR LAUE    (M/L) : M                                  
REMARK 200  WAVELENGTH OR RANGE        (A) : 1.5418                             
REMARK 200  MONOCHROMATOR                  : GRAPHITE(002)                      
REMARK 200  OPTICS                         : COLLIMATOR                         
REMARK 200                                                                      
REMARK 200  DETECTOR TYPE                  : DIFFRACTOMETER                     
REMARK 200  DETECTOR MANUFACTURER          : ENRAF-NONIUS FAST                  
REMARK 200  INTENSITY-INTEGRATION SOFTWARE : ENRAF-NONIUS                       
REMARK 200  DATA SCALING SOFTWARE          : NULL                               
REMARK 200                                                                      
REMARK 200  NUMBER OF UNIQUE REFLECTIONS   : 7726                               
REMARK 200  RESOLUTION RANGE HIGH      (A) : 1.250                              
REMARK 200  RESOLUTION RANGE LOW       (A) : 100.000                            
REMARK 200  REJECTION CRITERIA  (SIGMA(I)) : -3.000                             
REMARK 200                                                                      
REMARK 200 OVERALL.                                                             
REMARK 200  COMPLETENESS FOR RANGE     (%) : 99.9                               
REMARK 200  DATA REDUNDANCY                : 1.000                              
REMARK 200  R MERGE                    (I) : NULL                               
REMARK 200  R SYM                      (I) : NULL                               
REMARK 200  <I/SIGMA(I)> FOR THE DATA SET  : 85.4100                            
REMARK 200                                                                      
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.                                     
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.20                     
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE LOW  (A) : 1.24                     
REMARK 200  COMPLETENESS FOR SHELL     (%) : 99.0                               
REMARK 200  DATA REDUNDANCY IN SHELL       : 1.00                               
REMARK 200  R MERGE FOR SHELL          (I) : NULL                               
REMARK 200  R SYM FOR SHELL            (I) : NULL                               
REMARK 200  <I/SIGMA(I)> FOR SHELL         : 35.53                              
REMARK 200                                                                      
REMARK 200 DIFFRACTION PROTOCOL: NULL                                           
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT        
REMARK 200 SOFTWARE USED: SHELXL-97                                             
REMARK 200 STARTING MODEL: PDB ENTRY 1GMA                                       
REMARK 200                                                                      
REMARK 200 REMARK: NULL                                                         
REMARK 280                                                                      
REMARK 280 CRYSTAL                                                              
REMARK 280 SOLVENT CONTENT, VS   (%): 25.57                                     
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.65                     
REMARK 280                                                                      
REMARK 280 CRYSTALLIZATION CONDITIONS: CRYSTALLIZED BY BATCH METHODS FROM A     
REMARK 280  SATURATED SOLUTION OF GRAMICIDIN D IN METHANOL., PH 7.0, BATCH      
REMARK 280  METHOD                                                              
REMARK 290                                                                      
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY                                            
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1                         
REMARK 290                                                                      
REMARK 290      SYMOP   SYMMETRY                                                
REMARK 290     NNNMMM   OPERATOR                                                
REMARK 290       1555   X,Y,Z                                                   
REMARK 290       2555   -X,Y+1/2,-Z                                             
REMARK 290                                                                      
REMARK 290     WHERE NNN -> OPERATOR NUMBER                                     
REMARK 290           MMM -> TRANSLATION VECTOR                                  
REMARK 290                                                                      
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS                            
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM             
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY                
REMARK 290 RELATED MOLECULES.                                                   
REMARK 290   SMTRY1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 290   SMTRY2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 290   SMTRY3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 290   SMTRY1   2 -1.000000  0.000000  0.000000        0.00000            
REMARK 290   SMTRY2   2  0.000000  1.000000  0.000000       13.00700            
REMARK 290   SMTRY3   2  0.000000  0.000000 -1.000000        0.00000            
REMARK 290                                                                      
REMARK 290 REMARK: NULL                                                         
REMARK 300                                                                      
REMARK 300 BIOMOLECULE: 1                                                       
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM                
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN                  
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON               
REMARK 300 BURIED SURFACE AREA.                                                 
REMARK 350                                                                      
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN           
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE                
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS          
REMARK 350 GIVEN BELOW.  BOTH NON-CRYSTALLOGRAPHIC AND                          
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.                               
REMARK 350                                                                      
REMARK 350 BIOMOLECULE: 1                                                       
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC                           
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B                                  
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 400                                                                      
REMARK 400 COMPOUND                                                             
REMARK 400 GRAMICIDIN IS A HETEROGENEOUS MIXTURE OF SEVERAL COMPOUNDS           
REMARK 400  INCLUDING GRAMICIDIN A, B AND C WHICH ARE OBTAINED FROM             
REMARK 400  BACILLUS BREVIS AND CALLED COLLECTIVELY GRAMICIDIN D.               
REMARK 400  HERE, GRAMICIDIN D IS REPRESENTED BY THE SEQUENCE (SEQRES)          
REMARK 400                                                                      
REMARK 400 THE GRAMICIDIN D IS POLYPEPTIDE, A MEMBER OF ANTIBIOTIC CLASS.       
REMARK 400                                                                      
REMARK 400  GROUP: 1                                                            
REMARK 400   NAME: GRAMICIDIN D                                                 
REMARK 400   CHAIN: A, B                                                        
REMARK 400   COMPONENT_1: PEPTIDE LIKE POLYMER                                  
REMARK 400   DESCRIPTION: GRAMICIDIN D IS A HEXADECAMERIC HELICAL PEPTIDE WITH  
REMARK 400                ALTERNATING D,L CHARACTERISTICS. THE N-TERM IS        
REMARK 400                FORMYLATED (RESIDUE 1). THE C-TERM IS CAPPED WITH     
REMARK 400                ETHANOLAMINE (RESIDUE 16).                            
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT                     
REMARK 500                                                                      
REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT.                            
REMARK 500                                                                      
REMARK 500  ATM1  RES C  SSEQI   ATM2  RES C  SSEQI           DISTANCE          
REMARK 500   HE1  TRP A     9     H1   MOH A   515              1.31            
REMARK 500   HO   MOH A   515     O    MOH B   504              1.52            
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: CLOSE CONTACTS                                             
REMARK 500                                                                      
REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC             
REMARK 500 SYMMETRY ARE IN CLOSE CONTACT.  AN ATOM LOCATED WITHIN 0.15          
REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A           
REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375             
REMARK 500 INSTEAD OF REMARK 500.  ATOMS WITH NON-BLANK ALTERNATE               
REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS.            
REMARK 500                                                                      
REMARK 500 DISTANCE CUTOFF:                                                     
REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS              
REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS                  
REMARK 500                                                                      
REMARK 500  ATM1  RES C  SSEQI   ATM2  RES C  SSEQI  SSYMOP   DISTANCE          
REMARK 500   HE1  TRP B    11     HO   MOH A   519     2654     1.26            
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: TORSION ANGLES                                             
REMARK 500                                                                      
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:            
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;               
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).                             
REMARK 500                                                                      
REMARK 500 STANDARD TABLE:                                                      
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)                    
REMARK 500                                                                      
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-           
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400            
REMARK 500                                                                      
REMARK 500  M RES CSSEQI        PSI       PHI                                   
REMARK 500    TRP A  13       99.32   -167.58                                   
REMARK 500    TRP A  15       89.49   -153.59                                   
REMARK 500    TRP B  11       98.04   -166.98                                   
REMARK 500    TRP B  15       75.92   -157.95                                   
REMARK 500    TRP B  15       83.62   -157.95                                   
REMARK 500    TRP B  15       84.70   -157.95                                   
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 800                                                                      
REMARK 800 SITE                                                                 
REMARK 800 SITE_IDENTIFIER: AC1                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN A OF GRAMICIDIN A           
REMARK 800                                                                      
REMARK 800 SITE_IDENTIFIER: AC2                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN B OF GRAMICIDIN A           
REMARK 900                                                                      
REMARK 900 RELATED ENTRIES                                                      
REMARK 900 RELATED ID: 1TK2   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF GRAMICIDIN S COMPLEXED WITH ALKALINE            
REMARK 900 PROTEINASE SAVINASE                                                  
REMARK 900 RELATED ID: 2XDC   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF GRAMICIDIN A FROM CRYSTALS GROWN IN A LIPID     
REMARK 900 CUBIC PHASE.                                                         
REMARK 900 RELATED ID: 1AV2   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF GRAMICIDIN A COMPLEXED WITH CESIUM CHLORIDE     
REMARK 900 RELATED ID: 1BDW   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF GRAMICIDIN A FROM BACILLUS BREVIS               
REMARK 900 RELATED ID: 1C4D   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF GRAMICIDIN A COMPLEXED WITH CESIUM CHLORIDE     
REMARK 900 RELATED ID: 1GMK   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF GRAMICIDIN A COMPLRXED WITH POTASSIUM           
REMARK 900 THIOCYANATE                                                          
REMARK 900 RELATED ID: 1GRM   RELATED DB: PDB                                   
REMARK 900 SOLUTION STRUCTURE OF THE GRAMICIDIN A                               
REMARK 900 RELATED ID: 1JNO   RELATED DB: PDB                                   
REMARK 900 SOLUTION STRUCTURE OF GRAMICIDIN A IN SODIUM DODECYL SULFATE         
REMARK 900 MICELLES                                                             
REMARK 900 RELATED ID: 1KQE   RELATED DB: PDB                                   
REMARK 900 SOLUTION STRUCTURE OF A LINKED SHORTENED GRAMICIDIN A IN BENZENE/    
REMARK 900 ACETONE 10:1                                                         
REMARK 900 RELATED ID: 1MAG   RELATED DB: PDB                                   
REMARK 900 SOLID STATE NMR STRUCTURE OF GRAMICIDIN A IN HYDRATED DMPC BILAYERS, 
REMARK 900 RELATED ID: 1MIC   RELATED DB: PDB                                   
REMARK 900 SOLUTION STRUCTURE OF GRAMICIDIN A IN METHANOL IN THE PRESENCE OF    
REMARK 900 CACL                                                                 
REMARK 900 RELATED ID: 1NG8   RELATED DB: PDB                                   
REMARK 900 SOLUTION STRUCTURE OF GRAMICIDIN A (W15G) IN SODIUM DODECYL SULFATE  
REMARK 900 MICELLES                                                             
REMARK 900 RELATED ID: 1NRM   RELATED DB: PDB                                   
REMARK 900 SOLUTION STRUCTURE OF GRAMICIDIN A IN DODECYL PHOSPHOCHOLINE         
REMARK 900 MICELLES                                                             
REMARK 900 RELATED ID: 1NRU   RELATED DB: PDB                                   
REMARK 900 SOLUTION STRUCTURE OF GRAMICIDIN A IN DODECYL PHOSPHOCHOLINE         
REMARK 900 MICELLES IN THE PRESENCE OF EXCESS NA+                               
REMARK 900 RELATED ID: 1NT5   RELATED DB: PDB                                   
REMARK 900 SOLUTION STRUCTURE OF GRAMICIDIN A (V1F) IN SODIUM DODECYL SULFATE   
REMARK 900 MICELLES                                                             
REMARK 900 RELATED ID: 1JO3   RELATED DB: PDB                                   
REMARK 900 SOLUTION STRUCTURE OF GRAMICIDIN B IN SODIUM DODECYL SULFATE         
REMARK 900 MICELLES                                                             
REMARK 900 RELATED ID: 1JO4   RELATED DB: PDB                                   
REMARK 900 SOLUTION STRUCTURE OF GRAMICIDIN C IN SODIUM DODECYL SULFATE         
REMARK 900 MICELLES                                                             
REMARK 900 RELATED ID: 1NT6   RELATED DB: PDB                                   
REMARK 900 SOLUTION STRUCTURE OF F1-GRAMICIDIN C IN SODIUM DODECYL SULFATE      
REMARK 900 MICELLES                                                             
REMARK 900 RELATED ID: 1TKQ   RELATED DB: PDB                                   
REMARK 900 SOLUTION STRUCTURE OF A LINKED UNSYMMETRIC GRAMICIDIN A IN A         
REMARK 900 MEMBRANE-ISOELECTRICAL SOLVENTS MIXTURE, IN THE PRESENCE OF CSCL     
REMARK 900 RELATED ID: 1W5U   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF GRAMICIDIN D IN ETHANOL                         
REMARK 900 RELATED ID: 2IZQ   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF GRAMICIDIN D COMPLEX WITH KI IN METHANOL        
REMARK 900 RELATED ID: 3L8L   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF GRAMICIDIN D COMPLEX WITH NAI                   
REMARK 900 RELATED ID: 1AL4   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF GRAMICIDIN D IN N-PROPANOL                      
REMARK 900 RELATED ID: 1ALZ   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF GRAMICIDIN D IN ETHANOL                         
DBREF  1ALX A    1    16  NOR    NOR00243 NOR00243         1     16             
DBREF  1ALX B    1    16  NOR    NOR00243 NOR00243         1     16             
SEQADV 1ALX TYR A   11  NOR  NOR00243  TRP    11 MICROHETEROGENEITY             
SEQRES   1 A   16  FVA GLY ALA DLE ALA DVA VAL DVA TRP DLE TYR DLE TRP          
SEQRES   2 A   16  DLE TRP ETA                                                  
SEQRES   1 B   16  FVA GLY ALA DLE ALA DVA VAL DVA TRP DLE TRP DLE TRP          
SEQRES   2 B   16  DLE TRP ETA                                                  
HET    FVA  A   1      19                                                       
HET    DLE  A   4      19                                                       
HET    DVA  A   6      16                                                       
HET    DVA  A   8      16                                                       
HET    DLE  A  10      19                                                       
HET    DLE  A  12      19                                                       
HET    DLE  A  14      19                                                       
HET    ETA  A  16      30                                                       
HET    FVA  B   1      19                                                       
HET    DLE  B   4      19                                                       
HET    DVA  B   6      26                                                       
HET    DVA  B   8      26                                                       
HET    DLE  B  10      32                                                       
HET    DLE  B  12      19                                                       
HET    DLE  B  14      19                                                       
HET    ETA  B  16      30                                                       
HET    MOH  A 501       6                                                       
HET    MOH  A 502       6                                                       
HET    MOH  A 505       6                                                       
HET    MOH  A 506       6                                                       
HET    MOH  A 508       6                                                       
HET    MOH  A 515      12                                                       
HET    MOH  A 516      12                                                       
HET    MOH  A 518      12                                                       
HET    MOH  A 519      24                                                       
HET    MOH  B 503      12                                                       
HET    MOH  B 504       6                                                       
HET    MOH  B 507       6                                                       
HET    MOH  B 509       6                                                       
HET    MOH  B 510       6                                                       
HET    MOH  B 511       6                                                       
HET    MOH  B 512      12                                                       
HET    MOH  B 513      12                                                       
HET    MOH  B 514      12                                                       
HET    MOH  B 517      12                                                       
HET    MOH  B 520      30                                                       
HETNAM     FVA N-FORMYL-L-VALINE                                                
HETNAM     DLE D-LEUCINE                                                        
HETNAM     DVA D-VALINE                                                         
HETNAM     ETA ETHANOLAMINE                                                     
HETNAM     MOH METHANOL                                                         
FORMUL   1  FVA    2(C6 H11 N O3)                                               
FORMUL   1  DLE    8(C6 H13 N O2)                                               
FORMUL   1  DVA    4(C5 H11 N O2)                                               
FORMUL   1  ETA    2(C2 H7 N O)                                                 
FORMUL   3  MOH    20(C H4 O)                                                   
SHEET    1  AA 2 GLY A   2  DLE A  14  0                                        
SHEET    2  AA 2 GLY B   2  DLE B  14 -1  O  ALA B   3   N  TRP A  13           
LINK         C   FVA A   1                 N   GLY A   2     1555   1555  1.30  
LINK         C   ALA A   3                 N   DLE A   4     1555   1555  1.32  
LINK         C   DLE A   4                 N   ALA A   5     1555   1555  1.32  
LINK         C   ALA A   5                 N   DVA A   6     1555   1555  1.32  
LINK         C   DVA A   6                 N   VAL A   7     1555   1555  1.30  
LINK         C   VAL A   7                 N   DVA A   8     1555   1555  1.32  
LINK         C   DVA A   8                 N   TRP A   9     1555   1555  1.35  
LINK         C   TRP A   9                 N   DLE A  10     1555   1555  1.33  
LINK         C   DLE A  10                 N  BTRP A  11     1555   1555  1.35  
LINK         C   DLE A  10                 N  ATYR A  11     1555   1555  1.35  
LINK         C  ATYR A  11                 N   DLE A  12     1555   1555  1.36  
LINK         C  BTRP A  11                 N   DLE A  12     1555   1555  1.36  
LINK         C   DLE A  12                 N   TRP A  13     1555   1555  1.28  
LINK         C   TRP A  13                 N   DLE A  14     1555   1555  1.34  
LINK         C   DLE A  14                 N   TRP A  15     1555   1555  1.32  
LINK         C   TRP A  15                 N  AETA A  16     1555   1555  1.31  
LINK         C   TRP A  15                 N  CETA A  16     1555   1555  1.32  
LINK         C   TRP A  15                 N  BETA A  16     1555   1555  1.32  
LINK         C   FVA B   1                 N   GLY B   2     1555   1555  1.32  
LINK         C   ALA B   3                 N   DLE B   4     1555   1555  1.31  
LINK         C   DLE B   4                 N   ALA B   5     1555   1555  1.34  
LINK         C   ALA B   5                 N   DVA B   6     1555   1555  1.32  
LINK         C   DVA B   6                 N   VAL B   7     1555   1555  1.33  
LINK         C   VAL B   7                 N   DVA B   8     1555   1555  1.33  
LINK         C   DVA B   8                 N   TRP B   9     1555   1555  1.32  
LINK         C   TRP B   9                 N   DLE B  10     1555   1555  1.33  
LINK         C   DLE B  10                 N   TRP B  11     1555   1555  1.35  
LINK         C   TRP B  11                 N   DLE B  12     1555   1555  1.32  
LINK         C   DLE B  12                 N   TRP B  13     1555   1555  1.31  
LINK         C   TRP B  13                 N   DLE B  14     1555   1555  1.32  
LINK         C   DLE B  14                 N   TRP B  15     1555   1555  1.32  
LINK         C   TRP B  15                 N  BETA B  16     1555   1555  1.33  
LINK         C   TRP B  15                 N  CETA B  16     1555   1555  1.34  
LINK         C   TRP B  15                 N  AETA B  16     1555   1555  1.34  
SITE     1 AC1 15 GLY B   2  ALA B   3  DLE B   4  ALA B   5                    
SITE     2 AC1 15 DVA B   6  VAL B   7  DVA B   8  TRP B   9                    
SITE     3 AC1 15 DLE B  10  TRP B  11  DLE B  12  TRP B  13                    
SITE     4 AC1 15 DLE B  14  TRP B  15  ETA B  16                               
SITE     1 AC2 15 GLY A   2  ALA A   3  DLE A   4  ALA A   5                    
SITE     2 AC2 15 DVA A   6  VAL A   7  DVA A   8  TRP A   9                    
SITE     3 AC2 15 DLE A  10  TYR A  11  DLE A  12  TRP A  13                    
SITE     4 AC2 15 DLE A  14  TRP A  15  ETA A  16                               
CRYST1   14.907   26.014   31.911  90.00  92.03  90.00 P 1 21 1      2          
ORIGX1      1.000000  0.000000  0.000000        0.00000                         
ORIGX2      0.000000  1.000000  0.000000        0.00000                         
ORIGX3      0.000000  0.000000  1.000000        0.00000                         
SCALE1      0.067083  0.000000  0.002378        0.00000                         
SCALE2      0.000000  0.038441  0.000000        0.00000                         
SCALE3      0.000000  0.000000  0.031357        0.00000                         
MTRIX1   1  0.968610  0.175300 -0.176240       -0.39000    1                    
MTRIX2   1  0.178140 -0.984010  0.000300       -1.54000    1                    
MTRIX3   1 -0.173370 -0.031690 -0.984350       -6.71000    1                    
HETATM    1  C   FVA A   1       5.728  -2.362 -18.583  1.00  7.68           C  
ANISOU    1  C   FVA A   1     1087   1164    666   -109      1    -56       C  
HETATM    2  N   FVA A   1       7.209  -3.526 -20.060  1.00  8.37           N  
ANISOU    2  N   FVA A   1     1563    945    673   -144    121   -155       N  
HETATM    3  O   FVA A   1       6.534  -2.502 -17.641  1.00  8.74           O  
ANISOU    3  O   FVA A   1     1208   1351    761     27    -70     32       O  
HETATM    4  CA  FVA A   1       5.812  -3.318 -19.754  1.00  9.39           C  
ANISOU    4  CA  FVA A   1     1684   1050    834   -193    275    -71       C  
HETATM    5  CB  FVA A   1       5.088  -4.626 -19.356  1.00 10.59           C  
ANISOU    5  CB  FVA A   1     1602    973   1448   -189    251    -78       C  
HETATM    6  CG1 FVA A   1       5.623  -5.315 -18.092  1.00 12.55           C  
ANISOU    6  CG1 FVA A   1     1566   1236   1965   -536     36    450       C  
HETATM    7  CG2 FVA A   1       3.585  -4.434 -19.166  1.00 12.85           C  
ANISOU    7  CG2 FVA A   1     1524   1802   1555   -229    108     84       C  
HETATM    8  H   FVA A   1       7.755  -3.603 -19.400  1.00 10.05           H  
ANISOU    8  H   FVA A   1     1273   1273   1273      0      0      0       H  
HETATM    9  HA  FVA A   1       5.364  -2.922 -20.531  1.00 11.27           H  
ANISOU    9  HA  FVA A   1     1427   1427   1427      0      0      0       H  
HETATM   10  HB  FVA A   1       5.205  -5.256 -20.098  1.00 12.71           H  
ANISOU   10  HB  FVA A   1     1610   1610   1610      0      0      0       H  
HETATM   11 HG11 FVA A   1       6.271  -4.747 -17.668  1.00 18.82           H  
ANISOU   11 HG11 FVA A   1     2384   2384   2384      0      0      0       H  
HETATM   12 HG12 FVA A   1       4.898  -5.480 -17.485  1.00 18.82           H  
ANISOU   12 HG12 FVA A   1     2384   2384   2384      0      0      0       H  
HETATM   13 HG13 FVA A   1       6.037  -6.148 -18.331  1.00 18.82           H  
ANISOU   13 HG13 FVA A   1     2384   2384   2384      0      0      0       H  
HETATM   14  O1  FVA A   1       7.053  -3.409 -22.314  1.00  8.86           O  
ANISOU   14  O1  FVA A   1     1893    859    614    -28     23    -68       O  
HETATM   15 HG21 FVA A   1       3.375  -3.497 -19.198  1.00 19.27           H  
ANISOU   15 HG21 FVA A   1     2441   2441   2441      0      0      0       H  
HETATM   16  CN  FVA A   1       7.708  -3.606 -21.290  1.00  8.29           C  
ANISOU   16  CN  FVA A   1     1709    834    607   -100      5   -368       C  
HETATM   17 HG22 FVA A   1       3.112  -4.892 -19.865  1.00 19.27           H  
ANISOU   17 HG22 FVA A   1     2441   2441   2441      0      0      0       H  
HETATM   18 HG23 FVA A   1       3.322  -4.791 -18.314  1.00 19.27           H  
ANISOU   18 HG23 FVA A   1     2441   2441   2441      0      0      0       H  
HETATM   19  HN  FVA A   1       8.608  -3.824 -21.383  1.00  9.95           H  
ANISOU   19  HN  FVA A   1     1260   1260   1260      0      0      0       H  
ATOM     20  N   GLY A   2       4.860  -1.403 -18.654  1.00  6.66           N  
ANISOU   20  N   GLY A   2      964    811    755   -364    -38    118       N  
ATOM     21  CA  GLY A   2       4.819  -0.447 -17.538  1.00  8.15           C  
ANISOU   21  CA  GLY A   2     1119    966   1010   -374    102   -157       C  
ATOM     22  C   GLY A   2       5.996   0.497 -17.515  1.00  6.00           C  
ANISOU   22  C   GLY A   2      661    972    646    -86     45    -35       C  
ATOM     23  O   GLY A   2       6.530   0.847 -18.566  1.00  6.91           O  
ANISOU   23  O   GLY A   2      932   1051    641    -14    102    121       O  
ATOM     24  H   GLY A   2       4.329  -1.328 -19.327  1.00  7.99           H  
ANISOU   24  H   GLY A   2     1012   1012   1012      0      0      0       H  
ATOM     25  HA2 GLY A   2       4.001   0.071 -17.598  1.00  9.77           H  
ANISOU   25  HA2 GLY A   2     1237   1237   1237      0      0      0       H  
ATOM     26  HA3 GLY A   2       4.796  -0.941 -16.703  1.00  9.77           H  
ANISOU   26  HA3 GLY A   2     1237   1237   1237      0      0      0       H  
ATOM     82  N   VAL A   7       7.057  -2.426  -8.097  1.00  5.71           N  
ANISOU   82  N   VAL A   7      580   1100    490    -81     10     35       N  
ATOM     83  CA  VAL A   7       5.748  -1.870  -7.659  1.00  7.36           C  
ANISOU   83  CA  VAL A   7      757   1406    635     81    238    107       C  
ATOM     84  C   VAL A   7       5.994  -0.864  -6.567  1.00  6.19           C  
ANISOU   84  C   VAL A   7      546   1321    487    204    235    270       C  
ATOM     85  O   VAL A   7       6.491  -1.176  -5.499  1.00  8.68           O  
ANISOU   85  O   VAL A   7     1337   1383    577    617      9     49       O  
ATOM     86  CB AVAL A   7       4.768  -2.986  -7.240  0.50  8.65           C  
ANISOU   86  CB AVAL A   7      838   1686    764   -191    164     32       C  
ATOM     87  CB BVAL A   7       4.751  -2.960  -7.249  0.50  8.41           C  
ANISOU   87  CB BVAL A   7      757   1580    857    -38    310     58       C  
ATOM     88  CG1AVAL A   7       5.366  -3.835  -6.121  0.50  8.57           C  
ANISOU   88  CG1AVAL A   7     1275   1107    873    -31    175   -124       C  
ATOM     89  CG1BVAL A   7       4.641  -4.037  -8.324  0.50  5.90           C  
ANISOU   89  CG1BVAL A   7      733    771    739    479    217    492       C  
ATOM     90  CG2AVAL A   7       3.423  -2.398  -6.842  0.50  8.66           C  
ANISOU   90  CG2AVAL A   7      861   1548    882   -269    240    347       C  
ATOM     91  CG2BVAL A   7       5.113  -3.547  -5.893  0.50  9.02           C  
ANISOU   91  CG2BVAL A   7      771   1937    719   -187    618    171       C  
ATOM     92  H   VAL A   7       7.722  -2.435  -7.553  1.00  6.86           H  
ANISOU   92  H   VAL A   7      869    869    869      0      0      0       H  
ATOM     93  HA  VAL A   7       5.354  -1.396  -8.421  1.00  8.84           H  
ANISOU   93  HA  VAL A   7     1120   1120   1120      0      0      0       H  
ATOM     94  HB AVAL A   7       4.624  -3.567  -8.016  0.50 10.39           H  
ANISOU   94  HB AVAL A   7     1316   1316   1316      0      0      0       H  
ATOM     95  HB BVAL A   7       3.870  -2.538  -7.163  0.50 10.09           H  
ANISOU   95  HB BVAL A   7     1278   1278   1278      0      0      0       H  
ATOM     96 HG11AVAL A   7       6.228  -3.487  -5.881  0.50 12.85           H  
ANISOU   96 HG11AVAL A   7     1627   1627   1627      0      0      0       H  
ATOM     97 HG11BVAL A   7       5.501  -4.440  -8.462  0.50  8.85           H  
ANISOU   97 HG11BVAL A   7     1121   1121   1121      0      0      0       H  
ATOM     98 HG12AVAL A   7       4.786  -3.810  -5.356  0.50 12.85           H  
ANISOU   98 HG12AVAL A   7     1627   1627   1627      0      0      0       H  
ATOM     99 HG12BVAL A   7       4.015  -4.708  -8.042  0.50  8.85           H  
ANISOU   99 HG12BVAL A   7     1121   1121   1121      0      0      0       H  
ATOM    100 HG13AVAL A   7       5.459  -4.741  -6.422  0.50 12.85           H  
ANISOU  100 HG13AVAL A   7     1627   1627   1627      0      0      0       H  
ATOM    101 HG13BVAL A   7       4.337  -3.640  -9.144  0.50  8.85           H  
ANISOU  101 HG13BVAL A   7     1121   1121   1121      0      0      0       H  
ATOM    102 HG21AVAL A   7       3.465  -1.440  -6.890  0.50 12.99           H  
ANISOU  102 HG21AVAL A   7     1645   1645   1645      0      0      0       H  
ATOM    103 HG21BVAL A   7       5.196  -2.840  -5.250  0.50 13.53           H  
ANISOU  103 HG21BVAL A   7     1714   1714   1714      0      0      0       H  
ATOM    104 HG22AVAL A   7       2.743  -2.719  -7.440  0.50 12.99           H  
ANISOU  104 HG22AVAL A   7     1645   1645   1645      0      0      0       H  
ATOM    105 HG22BVAL A   7       4.424  -4.155  -5.613  0.50 13.53           H  
ANISOU  105 HG22BVAL A   7     1714   1714   1714      0      0      0       H  
ATOM    106 HG23AVAL A   7       3.211  -2.664  -5.944  0.50 12.99           H  
ANISOU  106 HG23AVAL A   7     1645   1645   1645      0      0      0       H  
ATOM    107 HG23BVAL A   7       5.947  -4.018  -5.961  0.50 13.53           H  
ANISOU  107 HG23BVAL A   7     1714   1714   1714      0      0      0       H  
ATOM    167  N  ATYR A  11      11.693  -0.212  -0.648  0.50  5.87           N  
ANISOU  167  N  ATYR A  11      649    877    703   -337     88    157       N  
ATOM    168  CA ATYR A  11      11.579  -1.600  -0.216  0.50  5.50           C  
ANISOU  168  CA ATYR A  11      777    926    385   -198    -26    184       C  
ATOM    169  C  ATYR A  11      11.037  -1.615   1.189  0.50  5.75           C  
ANISOU  169  C  ATYR A  11      965    760    458   -174    140     87       C  
ATOM    170  O  ATYR A  11      11.695  -1.247   2.139  0.50  6.62           O  
ANISOU  170  O  ATYR A  11     1144   1096    275   -331    133      4       O  
ATOM    171  CB ATYR A  11      12.857  -2.431  -0.344  0.50  6.49           C  
ANISOU  171  CB ATYR A  11      839   1018    606   -147     68   -143       C  
ATOM    172  CG ATYR A  11      12.847  -3.811   0.280  0.50  6.68           C  
ANISOU  172  CG ATYR A  11      827   1041    671     37    132   -108       C  
ATOM    173  CD1ATYR A  11      12.203  -4.884  -0.320  0.50  6.33           C  
ANISOU  173  CD1ATYR A  11      785    970    650     35    169    -95       C  
ATOM    174  CD2ATYR A  11      13.478  -4.090   1.497  0.50  7.66           C  
ANISOU  174  CD2ATYR A  11      852   1053   1005    132   -151   -115       C  
ATOM    175  CE1ATYR A  11      12.206  -6.148   0.236  0.24  6.72           C  
ANISOU  175  CE1ATYR A  11     1061   1004    489     50    121   -172       C  
ATOM    176  CE2ATYR A  11      13.475  -5.352   2.075  0.50  7.79           C  
ANISOU  176  CE2ATYR A  11      679   1295    987   -194   -228     94       C  
ATOM    177  CZ ATYR A  11      12.820  -6.396   1.443  0.24  6.72           C  
ANISOU  177  CZ ATYR A  11      878   1082    592    -22     38   -101       C  
ATOM    178  OH ATYR A  11      12.792  -7.644   2.012  0.24  9.15           O  
ANISOU  178  OH ATYR A  11     1393    989   1094    445    269     41       O  
ATOM    179  H  ATYR A  11      11.752   0.417  -0.065  0.50  7.04           H  
ANISOU  179  H  ATYR A  11      892    892    892      0      0      0       H  
ATOM    180  HA ATYR A  11      10.979  -2.092  -0.814  0.50  6.59           H  
ANISOU  180  HA ATYR A  11      835    835    835      0      0      0       H  
ATOM    181  HB2ATYR A  11      13.058  -2.529  -1.288  0.50  7.78           H  
ANISOU  181  HB2ATYR A  11      985    985    985      0      0      0       H  
ATOM    182  HB3ATYR A  11      13.584  -1.927   0.054  0.50  7.78           H  
ANISOU  182  HB3ATYR A  11      985    985    985      0      0      0       H  
ATOM    183  HD1ATYR A  11      11.755  -4.747  -1.124  0.50  7.60           H  
ANISOU  183  HD1ATYR A  11      963    963    963      0      0      0       H  
ATOM    184  HD2ATYR A  11      13.919  -3.400   1.938  0.24  9.19           H  
ANISOU  184  HD2ATYR A  11     1164   1164   1164      0      0      0       H  
ATOM    185  HE1ATYR A  11      11.785  -6.845  -0.214  0.50  8.07           H  
ANISOU  185  HE1ATYR A  11     1022   1022   1022      0      0      0       H  
ATOM    186  HE2ATYR A  11      13.911  -5.495   2.884  0.24  9.35           H  
ANISOU  186  HE2ATYR A  11     1184   1184   1184      0      0      0       H  
ATOM    187  HH ATYR A  11      13.372  -7.694   2.590  0.24 13.72           H  
ANISOU  187  HH ATYR A  11     1738   1738   1738      0      0      0       H  
ATOM    188  N  BTRP A  11      11.693  -0.212  -0.648  0.50  5.87           N  
ANISOU  188  N  BTRP A  11      649    877    703   -337     88    157       N  
ATOM    189  CA BTRP A  11      11.579  -1.600  -0.216  0.50  5.50           C  
ANISOU  189  CA BTRP A  11      777    926    385   -198    -26    184       C  
ATOM    190  C  BTRP A  11      11.037  -1.615   1.189  0.50  5.75           C  
ANISOU  190  C  BTRP A  11      965    760    458   -174    140     87       C  
ATOM    191  O  BTRP A  11      11.695  -1.247   2.139  0.50  6.62           O  
ANISOU  191  O  BTRP A  11     1144   1096    275   -331    133      4       O  
ATOM    192  CB BTRP A  11      12.938  -2.280  -0.163  0.50  6.06           C  
ANISOU  192  CB BTRP A  11      742   1028    533   -206     88    179       C  
ATOM    193  CG BTRP A  11      12.794  -3.766  -0.222  0.50  6.48           C  
ANISOU  193  CG BTRP A  11      830   1063    569     17     18    -98       C  
ATOM    194  CD1BTRP A  11      11.737  -4.535  -0.537  0.50  6.82           C  
ANISOU  194  CD1BTRP A  11      850    939    801    -81     93     30       C  
ATOM    195  CD2BTRP A  11      13.878  -4.632   0.065  0.50  7.05           C  
ANISOU  195  CD2BTRP A  11      843    954    882     88     91   -454       C  
ATOM    196  NE1BTRP A  11      12.056  -5.846  -0.484  0.76  6.88           N  
ANISOU  196  NE1BTRP A  11      928   1020    666    167    117   -401       N  
ATOM    197  CE2BTRP A  11      13.398  -5.946  -0.119  0.50  7.01           C  
ANISOU  197  CE2BTRP A  11     1191    912    559     36   -450   -273       C  
ATOM    198  CE3BTRP A  11      15.191  -4.447   0.443  0.76 10.57           C  
ANISOU  198  CE3BTRP A  11      798   1103   2115     92   -118   -221       C  
ATOM    199  CZ2BTRP A  11      14.225  -7.062   0.047  0.76 12.13           C  
ANISOU  199  CZ2BTRP A  11     1367   1184   2058    318   -561   -188       C  
ATOM    200  CZ3BTRP A  11      15.999  -5.552   0.599  0.76 12.97           C  
ANISOU  200  CZ3BTRP A  11     1217   1225   2488    429   -279   -631       C  
ATOM    201  CH2BTRP A  11      15.519  -6.863   0.434  0.76 13.63           C  
ANISOU  201  CH2BTRP A  11     1074   1168   2937    310   -212   -221       C  
ATOM    202  H  BTRP A  11      11.752   0.417  -0.065  0.50  7.04           H  
ANISOU  202  H  BTRP A  11      892    892    892      0      0      0       H  
ATOM    203  HA BTRP A  11      10.979  -2.092  -0.814  0.50  6.59           H  
ANISOU  203  HA BTRP A  11      835    835    835      0      0      0       H  
ATOM    204  HB2BTRP A  11      13.479  -1.978  -0.909  0.50  7.28           H  
ANISOU  204  HB2BTRP A  11      922    922    922      0      0      0       H  
ATOM    205  HB3BTRP A  11      13.391  -2.031   0.657  0.50  7.28           H  
ANISOU  205  HB3BTRP A  11      922    922    922      0      0      0       H  
ATOM    206  HD1BTRP A  11      10.896  -4.208  -0.762  0.50  8.18           H  
ANISOU  206  HD1BTRP A  11     1036   1036   1036      0      0      0       H  
ATOM    207  HE1BTRP A  11      11.526  -6.503  -0.647  0.50  8.25           H  
ANISOU  207  HE1BTRP A  11     1045   1045   1045      0      0      0       H  
ATOM    208  HE3BTRP A  11      15.525  -3.591   0.589  0.76 12.68           H  
ANISOU  208  HE3BTRP A  11     1606   1606   1606      0      0      0       H  
ATOM    209  HZ2BTRP A  11      13.901  -7.920  -0.102  0.76 14.56           H  
ANISOU  209  HZ2BTRP A  11     1844   1844   1844      0      0      0       H  
ATOM    210  HZ3BTRP A  11      16.893  -5.427   0.822  0.76 15.57           H  
ANISOU  210  HZ3BTRP A  11     1972   1972   1972      0      0      0       H  
ATOM    211  HH2BTRP A  11      16.079  -7.589   0.587  0.76 16.36           H  
ANISOU  211  HH2BTRP A  11     2072   2072   2072      0      0      0       H  
HETATM  298  CA AETA A  16      12.087   1.456  10.102  0.33  8.52           C  
ANISOU  298  CA AETA A  16     1417   1024    798     25   -306   -257       C  
HETATM  299  CA BETA A  16      12.744   1.819   9.921  0.33  8.61           C  
ANISOU  299  CA BETA A  16     1272   1235    765     43   -267   -154       C  
HETATM  300  CA CETA A  16      12.543   1.529   9.875  0.33  8.31           C  
ANISOU  300  CA CETA A  16     1310   1130    718    -37   -321   -198       C  
HETATM  301  N  AETA A  16      11.770   2.183   8.853  0.33  7.58           N  
ANISOU  301  N  AETA A  16     1088   1004    786    -86    -89   -138       N  
HETATM  302  N  BETA A  16      12.078   2.394   8.757  0.33  7.45           N  
ANISOU  302  N  BETA A  16     1158    980    694     41   -134   -204       N  
HETATM  303  N  CETA A  16      11.992   2.315   8.781  0.33  7.43           N  
ANISOU  303  N  CETA A  16     1143    963    718    -11   -144   -181       N  
HETATM  304  CB AETA A  16      13.539   1.769  10.475  0.33 10.20           C  
ANISOU  304  CB AETA A  16     1421   1463    991    -47   -324    -57       C  
HETATM  305  CB BETA A  16      12.142   0.462  10.276  0.33  8.40           C  
ANISOU  305  CB BETA A  16     1357    969    866    283   -420   -171       C  
HETATM  306  CB CETA A  16      14.060   1.349   9.824  0.33 10.08           C  
ANISOU  306  CB CETA A  16     1373   1396   1060     51   -416     46       C  
HETATM  307  O  AETA A  16      13.758   1.427  11.829  0.33 14.62           O  
ANISOU  307  O  AETA A  16     1606   2244   1706     55   -713   1258       O  
HETATM  308  O  BETA A  16      12.805  -0.526   9.487  0.33 10.90           O  
ANISOU  308  O  BETA A  16     1122   1250   1770   1019   -503    -93       O  
HETATM  309  O  CETA A  16      14.438   0.590   8.700  0.33 11.31           O  
ANISOU  309  O  CETA A  16     1154   1273   1871   -320    141   -290       O  
HETATM  310  HA1AETA A  16      11.975   0.501   9.970  0.33 10.23           H  
ANISOU  310  HA1AETA A  16     1296   1296   1296      0      0      0       H  
HETATM  311  HA1BETA A  16      12.653   2.421  10.676  0.33 10.34           H  
ANISOU  311  HA1BETA A  16     1310   1310   1310      0      0      0       H  
HETATM  312  HA1CETA A  16      12.126   0.653   9.868  0.33  9.97           H  
ANISOU  312  HA1CETA A  16     1263   1263   1263      0      0      0       H  
HETATM  313  HA2AETA A  16      11.491   1.739  10.814  0.33 10.23           H  
ANISOU  313  HA2AETA A  16     1296   1296   1296      0      0      0       H  
HETATM  314  HA2BETA A  16      13.690   1.714   9.733  0.33 10.34           H  
ANISOU  314  HA2BETA A  16     1310   1310   1310      0      0      0       H  
HETATM  315  HA2CETA A  16      12.310   1.958  10.713  0.33  9.97           H  
ANISOU  315  HA2CETA A  16     1263   1263   1263      0      0      0       H  
HETATM  316  HN1AETA A  16      11.967   1.831   8.093  0.33  9.09           H  
ANISOU  316  HN1AETA A  16     1151   1151   1151      0      0      0       H  
HETATM  317  HN1BETA A  16      12.266   2.099   7.972  0.33  8.94           H  
ANISOU  317  HN1BETA A  16     1132   1132   1132      0      0      0       H  
HETATM  318  HN1CETA A  16      12.208   2.076   7.984  0.33  8.92           H  
ANISOU  318  HN1CETA A  16     1130   1130   1130      0      0      0       H  
HETATM  319  HB1AETA A  16      14.141   1.263   9.907  0.33 12.24           H  
ANISOU  319  HB1AETA A  16     1550   1550   1550      0      0      0       H  
HETATM  320  HB1BETA A  16      12.268   0.277  11.219  0.33 10.08           H  
ANISOU  320  HB1BETA A  16     1277   1277   1277      0      0      0       H  
HETATM  321  HB1CETA A  16      14.487   2.219   9.785  0.33 12.09           H  
ANISOU  321  HB1CETA A  16     1531   1531   1531      0      0      0       H  
HETATM  322  HB2AETA A  16      13.716   2.713  10.342  0.33 12.24           H  
ANISOU  322  HB2AETA A  16     1550   1550   1550      0      0      0       H  
HETATM  323  HB2BETA A  16      11.191   0.458  10.086  0.33 10.08           H  
ANISOU  323  HB2BETA A  16     1277   1277   1277      0      0      0       H  
HETATM  324  HB2CETA A  16      14.360   0.902  10.631  0.33 12.09           H  
ANISOU  324  HB2CETA A  16     1531   1531   1531      0      0      0       H  
HETATM  325  HO AETA A  16      14.374   1.877  12.128  0.33 21.94           H  
ANISOU  325  HO AETA A  16     2779   2779   2779      0      0      0       H  
HETATM  326  HO BETA A  16      13.598  -0.556   9.696  0.33 16.35           H  
ANISOU  326  HO BETA A  16     2071   2071   2071      0      0      0       H  
HETATM  327  HO CETA A  16      15.097   0.139   8.884  0.33 16.97           H  
ANISOU  327  HO CETA A  16     2149   2149   2149      0      0      0       H  
TER     328      ETA A  16                                                      
END
